SCHEMBL7571399

SCHEMBL7571399

O=C1N=C(O)C(c2ccc(Cl)c(Cl)c2)=NC1Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 2/20 0.38
S1PR1 P21453 1/20 0.37
S1PR5 Q9H228 1/20 0.37
CYP26A1 O43174 1/20 0.37
PGR P06401 1/20 0.37
ESR2 Q92731 1/20 0.35
CCR2 P41597 2/20 0.35
RNASEH1 O60930 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
TBXA2R P21731 1/20 0.34
PTGER1 P34995 1/20 0.34
PTGER4 P35408 1/20 0.34
PTGFR P43088 1/20 0.34
PTGER3 P43115 1/20 0.34
PTGER2 P43116 1/20 0.34
PTGIR P43119 1/20 0.34
PTGDR Q13258 1/20 0.34
POLB P06746 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7570886 0.95 PSD (0.37) PTPN5S1PR1S1PR5PGRRNASEH1
SCHEMBL7570905 0.90 CYP26A1 (0.35) PTPN5CYP26A1ESR2HDAC3HDAC6
SCHEMBL7571248 0.88 HDAC3 (0.41) CYP26A1HDAC3HDAC6HTT
SCHEMBL7572646 0.85 BDKRB2 (0.41) CYP26A1HDAC3HDAC6HTT
SCHEMBL7576399 0.85 CNR2 (0.35) HDAC3HDAC6NPC1RAB9A
SCHEMBL7575515 0.85 ESR1 (0.37) CYP26A1ESR2HDAC3HDAC6MEN1
SCHEMBL7572458 0.82 BDKRB2 (0.42) HDAC3HDAC6
SCHEMBL7572631 0.82 CES2 (0.42) PTPN5CYP26A1HDAC3HDAC6CCKBR
SCHEMBL7572718 0.82 CES2 (0.43) HDAC3HDAC6MEN1KMT2A
SCHEMBL7570328 0.79 CES2 (0.45) HDAC3HDAC6HTTCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002085369-A1 INHIBITORS OF ANTHRAX LETHAL FACTOR ACTIVITY STRUCTURAL BIOINFORMATICS, INC. (US) 2002-10-31 WO disclosed